The Director Medical Affairs Inflammation leads and manages the Medical Affairs department for Inflammation/Immunology. This involves direct managerial responsibility for the medical team assigned to this Therapeutic Area (TA). The TA includes inflammatory diseases mainly in the area of rheumatology and inflammatory bowel disease and is directly involved in a new oral JAK inhibitor and the product pipeline in inflammatory diseases.
The Director Medical Affairs Inflammation leads the development and implementation of the Medical Therapeutic Area strategy and the Medical product strategy. This requires close national and international collaboration with colleagues. The Director Medical Affairs Inflammation also contributes to the cross-functional leadership in the assigned Therapeutic Area and to the leadership of the Medical Affairs Department. He/she represents Gilead Spain to internal and external stakeholders.
The role is office-based in Madrid and requires National and International travel (including for internal meetings and external scientific conferences).
The position reports to the Country Medical Director.